

In April’s CAC2 All-Member Webinar, Dr. Brian D. Crompton (pediatric oncologist at Dana Farber/Boston Children’s Hospital) and CAC2 Member Greg Harper (Living LFS) presented about the possibilities with emerging technology identifying circulating cancer cells with liquid biopsies, using Li-Fraumeni Syndrome as a case study.
The presentation below described the investigation into a liquid biopsy for Li-Fraumeni Syndrome patients and the EDISYN consortium and how nonprofits partnering with medical research centers to help empower patients and families.
Categories
- Blog Posts (57)
- Guest Blogs (8)
- Member Blogs (23)
- Survivorship Matters Blog (7)
- CAC2 News (13)
- Collaborative Achievements (14)
- Community News (108)
- Research Explained (6)
- Webinars (59)
Tags
#CancelChildhoodCancer
Advocacy
Annual Summit
Awareness
AYA
Best Practices
Biorepositories
CAC2 News
CAC2 Projects
Call to Action
Clinical Trials
Collaboration
Data
Delayed Diagnosis
Digest
Drug Development
Drug Shortages
Ethics
Family Support
FDA
Global News
Member Access
Nutrition
Prevention
project incubator
Psychosocial Support
Rare Cancers
Regulations
Research
research advocacy collaboration
Survivorship
Venture Philanthropy
Recent Posts
- CAC2 Childhood Cancer Community News Digest (May 9-22)
- CAC2 Childhood Cancer Community News Digest (May 2-8)
- Guest Blog–National Cancer Institute Launches the CCDI Childhood Cancer Data Catalog
- CAC2 Childhood Cancer Community News Digest (April 25-May 1)
- CAC2 News–Great.com Interviews Coalition Against Childhood Cancer About A Future Without Childhood Cancers